Pulmonary Hypertension in Adults with Congenital Heart Disease (ACHD): Case Study of Undetected Atria Septal Defect
DOI:
https://doi.org/10.14738/bjhr.1204.19186Keywords:
CHD in adults, Atrial septal defect, Pulmonary hypertension, Right heart dysfunction, Complications, Therapeutic advances, OperabilityAbstract
Patients with Congenital Heart Diseases (CHD) in developed economies reach adulthood (ACHD) due to early detection and medical advances. CHD may go undetected in developing nations during early childhood and present in later years as a result of complications. These include pulmonary hypertension (PH), right heart failure, atrial fibrillation, and stroke resulting from congenital heart conditions such as atrial (ASD) /ventricular septal defects (VSD). These debilitating illnesses have a high morbidity and mortality. A significant dilemma is the optimal management of patients with ASD complicated by PH. Echocardiography, with Right(R) and Left(L) heart studies are essential in evaluating these conditions. Therapeutic advances and newer pharmacological agents have improved survival in patients with PH. Failure of medical treatment may require surgical intervention. Operability and repair require expert opinion and specialist assessment. Lung transplant and closure of the ASD are remaining options.
References
Humbert, Marc, Gabor Kovacs, Marius M Hoeper, Roberto Badagliacca, Rolf M F Berger, Margarita Brida, Jørn Carlsen, Andrew J S Coats, Pilar Escribano-Subias, and Pisana Ferrari. 2022. “2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension: Developed by the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology.” European Heart Journal 43 (38): 3618–3731. https://academic.oup.com/eurheartj/article/43/38/3618/6673929
Jone, Pei-Ni, D Dunbar Ivy, Amanda Hauck, Tara Karamlou, Uyen Truong, Ryan D Coleman, Juan Pablo Sandoval, María Jesús del Cerro Marín, Pirooz Eghtesady, and Kathryn Tillman. 2023. “Pulmonary 252 Hypertension in Congenital Heart Disease: A Scientific Statement from the American Heart Association.” Circulation: Heart Failure 16 (7): e00080.
Takaya Y, Akagi T, Sakamoto I, Kanazawa H, Nakazawa G, Murakami T, Yao A, Nanasato M, Saji M, Hirokami M, Fuku Y, Hosokawa S, Tada N, Matsumoto K, Imai M, Nakagawa K, Ito H. Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension. Heart. 2022 Mar;108(5):382-387. doi: 10.1136/heartjnl-2021-319096. Epub 2021 Jun 15. PMID: 34415851; PMCID: PMC8862039.
Nashat H, Montanaro C, Li W, Kempny A, Wort SJ, Dimopoulos K, Gatzoulis MA, Babu-Narayan SV. Atrial septal defects and pulmonary arterial hypertension. J Thorac Dis. 2018 Sep;10(Suppl 24):S2953-S2965. doi: 10.21037/jtd.2018.08.92. PMID: 30305956; PMCID:PMC6174141
Banerjee, Ranjan, and Alexander R Opotowsky. 2024. “Update on Eisenmenger Syndrome – Review of Pathophysiology and Recent Progress in Risk Assessment and Management.” International Journal of Cardiology Congenital Heart Disease 17: 100520. https://doi.org/https://doi.org/10.1016/j.ijcchd.2024.100520.
D’Alto, Michele, and Gerhard-Paul Diller. 2014. “Pulmonary Hypertension in Adults with Congenital Heart Disease and Eisenmenger Syndrome: Current Advanced Management Strategies.” Heart 100 (17): 1322 LP –1328. https://doi.org/10.1136/heartjnl-2014-305574.
Rosenkranz, Stephan, Luke S Howard, Mardi Gomberg-Maitland, and Marius M Hoeper. 2020. “Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure.” Circulation 141 (8): 678–93. https://doi.org/10.1161/CIRCULATIONAHA.116.022362.
Thomas, Christopher A, Ryan J Anderson, David F Condon, and Vinicio A de Jesus Perez. 2020. “Diagnosis and Management of Pulmonary Hypertension in the Modern Era: Insights from the 6th World Symposium.” Pulmonary Therapy 6 (1): 9–22.
Murphy JG, Gersh BJ, McGoon MD, Mair DD, Porter CJ, Ilstrup DM, McGoon DC, Puga FJ, Kirklin JW, Danielson GK. Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med. 1990 Dec 13;323(24):1645-50. doi: 10.1056/NEJM199012133232401. PMID: 2233961.
Dimopoulos, Konstantinos, and Andrew Constantine. 2024. “Pulmonary Hypertension in Adults with Congenital Heart Disease.” In Pediatric Cardiology: Fetal, Pediatric, and Adult Congenital Heart Diseases, 2793–2842. Springer.
Tangcharoen, T., Ngernsritrakul, T., Chandavimol, M., Kamsorn, C., Apakuppakul, S. and Yamwong, S., 2024. Discordance between the European and the United States guideline criteria for atrial septal defect closure in adult patients with pulmonary hypertension and its clinical impact. Current Problems in Cardiology, 49(12), p.102869.
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, et al. 2020 ESC guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 7;42(6):563–645. doi:10.1093/eurheartj/ehaa554.
Forlemu, Arnold Nongmoh, Muhammad Ajmal, and Mehrdad Saririan. 2020. “Atrial Septal Defect with Eisenmenger Syndrome: A Rare Presentation.” Case Reports in Cardiology 2020 (1): 8681761.
Diller, Gerhard-Paul, Astrid E Lammers, and Erwin Oechslin. 2021. “Treatment of Adults with Eisenmenger Syndrome-State of the Art in the 21st Century: A Short Overview.” Cardiovascular Diagnosis and Therapy 11 (4): 1190–99. https://doi.org/10.21037/cdt-21-135.
Bulbulia, Bashir Ahmed. n.d. “An Overview of Pulmonary Hypertension (PH) and Vaso-Reactivity Testing with Inhaled Nitric Oxide; Available Therapies and the Anaesthetic Management of a PH Crises.”
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Dr B A Bulbulia. DA FCA (SA), Dr Anisa R Essop. MB BCh. (Wits)
This work is licensed under a Creative Commons Attribution 4.0 International License.
